DANA BRIGHT: Open Payments
NPI 1497166318 · SPARTANBURG, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$984 in 53 payments from 21 companies in 2025. Trend: 2023 $1,267 · 2024 $922 · 2025 $984
Food & beverage: $984
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 7 | $151 |
| ABBVIE INC. | 7 | $107 |
| Novo Nordisk Inc | 6 | $95 |
| Astellas Pharma US Inc | 4 | $88 |
| PFIZER INC. | 4 | $72 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $64 |
| Sumitomo Pharma America, Inc. | 3 | $58 |
| Corcept Therapeutics | 3 | $44 |
| Phathom Pharmaceuticals, Inc. | 2 | $36 |
| Eisai Inc. | 1 | $32 |
Products named: LEQVIO, Veozah, Kerendia, Ozempic, UBRELVY, GEMTESA, ELIQUIS, Korlym.
Industry payments across SC — which companies pay providers there.
